RankingsPricing
  1. JP-listed companies
  2. OLYMPUS CORPORATION

OLYMPUS CORPORATIONJP:7733

Market cap
¥3.2T
P/E ratio
13.2x
Back to summarized table
Income statementBalance sheetCash flow
Mar 31,
2018		Mar 31,
2019		Mar 31,
2020		Mar 31,
2021		Mar 31,
2022		Mar 31,
2023		Mar 31,
2024
Profit (loss) before tax76,66520,11786,61776,810149,873182,29435,854
Profit (loss) before tax from discontinued operations---8,819-52,4768,1727,413348,276
Depreciation and amortization52,91358,66968,30959,93764,61566,74165,940
Impairment losses-3,6185,5018423,3962,49864,568
Interest and dividend income-1,774-1,901-1,911-1,169-1,184-3,971-2,376
Interest expenses6,6694,6173,8103,9924,8656,0375,409
Loss (gain) on sale and retirement of fixed assets-----972-15,757456
Share of loss (profit) of investments accounted for using equity method47-603-485-595-1,492-491358
Gain on transfer of SSD-------349,037
Decrease (increase) in trade and other receivables1,7305,5841,276-9,718-10,981-27,013-11,851
Decrease (increase) in inventories-13,249-14,357-16,4014,024-2,097-26,852-19,072
Increase (decrease) in trade and other payables-13,7093,1147317,361-8,8278,770-5,935
Increase (decrease) in retirement benefit liability1,1671,632-2,303-987181-14,0991,013
Decrease (increase) in retirement benefit asset980-2,3912,136-718328952-3,269
Increase (decrease) in provisions9839,8669,6376,826-15,372-3,5559,083
Other9,8716,5106,75213,8472,48814,50742,765
Subtotal119,837119,890154,850152,770181,995197,474182,182
Interest received1,1321,2991,4568171,0173,9332,365
Dividends received6426024553521673811
Interest paid-6,375-4,622-3,689-3,355-4,286-5,388-4,803
Income taxes refund (paid)-19,281-21,193-19,528-26,462-9,164-97,567-137,390
Net cash provided by (used in) operating activities95,14666,943133,544124,122169,72998,49042,365
Payments into time deposits---1-40,002-1-2,136-
Purchase of property, plant and equipment-48,855-47,094-37,774-38,660-41,688-47,570-46,425
Proceeds from sale of property, plant and equipment5,6464,3001981,6214,48520,4601,471
Purchase of intangible assets-14,554-14,372-28,155-20,567-20,083-23,053-18,199
Purchase of investment securities-----1,977-3,705-28
Proceeds from sale of SSD business------379,091
Proceeds from transfer of collagen business and dental product sales businesses------1,656
Payments for acquisition of subsidiaries-8,636---44,541-21,837-3,859-
Proceeds from sale of subsidiaries2,400--1,328724-4,472
Collection of loans receivable1,4851,1931,7551,1671,2711,28453,373
Payments for contingent consideration------606-2,966
Expenditure based on stock acquisition agreements-------43,647
Claw back from cancellation of stock acquisition agreements------31,110
Other-873-1,607-42951,07977184
Net cash provided by (used in) investing activities-53,312-60,296-62,430-118,918-71,016-58,414359,992
Increase (decrease) in short-term borrowings and commercial papers-2,60864769,534-67,721-5,454-67-3
Repayments of lease liabilities---15,604-16,188-17,691-20,914-19,518
Repayments of long-term borrowings-66,307-64,302-58,874-10,606-26,246-13,547-40,000
Dividends paid-9,583-9,559-10,243-12,856-15,428-17,822-20,057
Dividends paid to non-controlling interests-79-368-126-170-188-226-183
Purchase of treasury shares-3,663-8-93,381-2-30,001-50,003-180,002
Redemption of bonds--25,000----40,000-10,000
Payments for acquisition of interests in subsidiaries from non-controlling interests----462---2,921
Other-2,315-3,730-341-182-1,802-599-3,326
Net cash provided by (used in) financing activities-51,058-82,948-19,46240,800-40,667-143,178-276,010
Effect of exchange rate changes on cash and cash equivalents998-375-3,4988,75727,0486,0429,074
Net increase (decrease) in cash and cash equivalents-8,226-76,67648,15454,76185,094-97,060135,421